Dysregulation of proteins involved in mitochondrial fusion (MFN1, MFN2, and OPA1) may contribute to aberrant mitochondrial morphology and impaired function in MASLD. This evidence concerns the gene OPA1 and metabolic dysfunction-associated steatotic liver disease.